Cargando…
Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
Apelin and Elabela (ELA) are endogenous ligands of angiotensin domain type 1 receptor-associated proteins (APJ). Apelin/ELA-APJ signal is widely distributed in the cardiovascular system of fetuse and adult. The signal is involved in the development of the fetal heart and blood vessels and regulating...
Autores principales: | Liu, Wei, Yan, Jialong, Pan, Weinan, Tang, Mengjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154429/ https://www.ncbi.nlm.nih.gov/pubmed/32309390 http://dx.doi.org/10.21037/atm.2020.02.07 |
Ejemplares similares
-
Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development—An Overview
por: Dawid, Monika, et al.
Publicado: (2021) -
The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?
por: Respekta, Natalia, et al.
Publicado: (2022) -
Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
por: Song, Jiawei, et al.
Publicado: (2022) -
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system
por: Yang, Peiran, et al.
Publicado: (2015) -
Apelin/APJ system: A key therapeutic target for liver disease
por: Lv, Shuang-Yu, et al.
Publicado: (2017)